NANO: Effectiveness and Safety of Small Aneurysm Coiling Trial
This is a prospective study to compare the safety and efficacy of treating small aneurysms.
ESCAPE: Changing the way stroke patients are treated
The ESCAPE trial is a testament to the importance of research and innovation in the evolution of treatment options for patients.
Our neurointerventional surgeons were key contributors to this landmark clinical trial that demonstrated the benefits of endovascular treatment compared to conventional treatment for patients with acute ischemic stroke. The results were published in the New England Journal of Medicine in 2015. The benefits were so significant that the study was halted early because of efficacy. Stroke is a disease that severely impairs functional independence or takes the lives of approximately 60-80% of patients within 90 days after onset. This study demonstrated that rapid endovascular treatment significantly improves functional outcomes and reduces mortality.
You Might Also Enjoy...
ATLAS: Next Generation Treatment for Intracranial Aneurysms
Safety and Effectiveness of the Treatment of Wide-Neck, Intracranial, Saccular Aneurysms with the Next Generation Neuroform Stent System.
COMPASS Trial: A Direct Aspiration First Pass Technique
Intravenous (IV) tissue plasminogen activator (tPA) administration has been shown to be safe and effective for treatment of Acute Ischemic Stroke (AIS) within 3 hours of symptom onset, and newer evidence has shown potential benefit out to 4.5 hours.
StrokeNet: Developed by the National Institute of Health
StrokeNet, developed by NIH, is the new structure for federal funding of all aspects of stroke research including prevention, acute treatment, and recovery / rehabilitation.
We Are Committed to Clinical Research
RIA has a rich history of participation in clinical research and innovation dating back to the 1980s. Many of our physicians believe it is important to contribute to science and advance medicine.
Barrel™: Study of the Reverse Medical Barrel™ Vascular Reconstruction Device
The full name of this study is: Barrel™: Study of the Reverse Medical Barrel™ Vascular Reconstruction Device for Adjunctive Treatment to Embolic Coils for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms.